Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects

BACKGROUND: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil as a topic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:An Bras Dermatol
Egile Nagusiak: Saraiva, Maria Isabel Ramos, Portocarrero, Larissa Karine Leite, Vieira, Marcella Amaral Horta Barbosa, Swiczar, Bethania Cabral Cavalli, Westin, Andrezza Telles
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Sociedade Brasileira de Dermatologia 2018
Gaiak:
Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6063094/
https://ncbi.nlm.nih.gov/pubmed/30066759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20186982
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak